Abbott Issues Medical Device Correction for FreeStyle Libre 3 Sensors
Abbott has initiated a medical device correction in the United States for specific batches of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose sensors after internal testing found that some units may deliver inaccurate low glucose readings.
FreeStyle Libre 3 Sensors | 26/11/2025 | By Darshana | 193
Abbott Inaugurates New Global Manufacturing Facility in Ireland
The Kilkenny facility is part of a EUR 440 million investment in Ireland, which includes a significant expansion of the company’s Donegal site, where a further 200 jobs are being created.
FreeStyle Libre 3 Sensors | 19/11/2024 | By Aishwarya | 607
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy